 | • レポートコード：GIR-107A15084 • 出版社/出版日：GlobalInfoResearch / 2021年7月 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、90ページ • 納品方法：Eメール（納期：2~3日） • 産業分類：医薬品 |
| Single User | ￥522,000 (USD3,480) | ▷ お問い合わせ |
| Multi User | ￥783,000 (USD5,220) | ▷ お問い合わせ |
| Corporate User | ￥1,044,000 (USD6,960) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 当調査資料では、リパーパシングドラッグのグローバル市場について調査・分析し、2021年から2026年までの市場予測をまとめております。リパーパシングドラッグの種類別市場規模（ジェネリック医薬品、臨床試験失敗医薬品）、用途別市場規模（心血管疾患、精神疾患、がん、その他）、地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、中国、日本、東南アジア、南米、中東、アフリカなど）、市場動向、企業別販売量と市場シェア、販売チャネルなどの情報を掲載しています。 ・リパーパシングドラッグの市場概要 ・企業情報（企業概要、製品概要、販売量、価格、売上）：Teva、Novartis、Mylan、Johnson & Johnson、Pfizer、Bausch Health、GSK、ChemRar Group、Glenmark、Fujifilm、Dr. Reddy、R-Pharma ・企業別市場シェア ・地域別市場分析2016年-2026年 ・種類別分析2016年-2026年：ジェネリック医薬品、臨床試験失敗医薬品 ・用途別分析2016年-2026年：心血管疾患、精神疾患、がん、その他 ・リパーパシングドラッグの北米市場規模2016年-2026年：アメリカ、カナダ、メキシコ ・リパーパシングドラッグのヨーロッパ市場規模2016年-2026年：ドイツ、イギリス、フランス、ロシア、イタリア ・リパーパシングドラッグのアジア市場規模2016年-2026年：中国、日本、韓国、インド、東南アジア、オーストラリア ・リパーパシングドラッグの南米市場規模2016年-2026年：ブラジル、アルゼンチン ・リパーパシングドラッグの中東・アフリカ市場規模2016年-2026年：サウジアラビア、トルコ、エジプト、南アフリカ ・販売チャネル、流通業者・代理店、顧客リスト ・調査の結果・結論 |
The Repurposed Drugs market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
According to our latest research, the global Repurposed Drugs size is estimated to be USD xx million in 2026 from USD xx million in 2020, with a change XX% between 2020 and 2021. The global Repurposed Drugs market size is expected to grow at a CAGR of xx% for the next five years.
Market segmentation
Repurposed Drugs market is split by Type and by Application. For the period 2016-2026, the growth among segments provide accurate calculations and forecasts for revenue by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type, covers
Generic Drugs
Clinical Trial Failed Drugs
Market segment by Application, can be divided into
Cardiovascular Diseases
Mental Illness
Cancer
Other
Market segment by players, this report covers
Teva
Novartis
Mylan
Johnson & Johnson
Pfizer
Bausch Health
GSK
ChemRar Group
Glenmark
Fujifilm
Dr. Reddy
R-Pharma
Market segment by regions, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia, and Rest of Asia-Pacific)
South America (Brazil, Argentina, Rest of South America)
Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
The content of the study subjects, includes a total of 12 chapters:
Chapter 1, to describe Repurposed Drugs product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top players of Repurposed Drugs, with revenue, gross margin and global market share of Repurposed Drugs from 2019 to 2021.
Chapter 3, the Repurposed Drugs competitive situation, revenue and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by type and application, with revenue and growth rate by type, application, from 2016 to 2026.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2016 to 2021.and Repurposed Drugs market forecast, by regions, type and application, with revenue, from 2021 to 2026.
Chapter 11 and 12, to describe Repurposed Drugs research findings and conclusion, appendix and data source.
1 Market Overview
1.1 Product Overview and Scope of Repurposed Drugs
1.2 Classification of Repurposed Drugs by Type
1.2.1 Overview: Global Repurposed Drugs Market Size by Type: 2020 Versus 2021 Versus 2026
1.2.2 Global Repurposed Drugs Revenue Market Share by Type in 2020
1.2.3 Generic Drugs
1.2.4 Clinical Trial Failed Drugs
1.3 Global Repurposed Drugs Market by Application
1.3.1 Overview: Global Repurposed Drugs Market Size by Application: 2020 Versus 2021 Versus 2026
1.3.2 Cardiovascular Diseases
1.3.3 Mental Illness
1.3.4 Cancer
1.3.5 Other
1.4 Global Repurposed Drugs Market Size & Forecast
1.5 Global Repurposed Drugs Market Size and Forecast by Region
1.5.1 Global Repurposed Drugs Market Size by Region: 2016 VS 2021 VS 2026
1.5.2 Global Repurposed Drugs Market Size by Region, (2016-2021)
1.5.3 North America Repurposed Drugs Market Size and Prospect (2016-2026)
1.5.4 Europe Repurposed Drugs Market Size and Prospect (2016-2026)
1.5.5 Asia-Pacific Repurposed Drugs Market Size and Prospect (2016-2026)
1.5.6 South America Repurposed Drugs Market Size and Prospect (2016-2026)
1.5.7 Middle East and Africa Repurposed Drugs Market Size and Prospect (2016-2026)
1.6 Market Drivers, Restraints and Trends
1.6.1 Repurposed Drugs Market Drivers
1.6.2 Repurposed Drugs Market Restraints
1.6.3 Repurposed Drugs Trends Analysis
2 Company Profiles
2.1 Teva
2.1.1 Teva Details
2.1.2 Teva Major Business
2.1.3 Teva Repurposed Drugs Product and Solutions
2.1.4 Teva Repurposed Drugs Revenue, Gross Margin and Market Share (2019-2021)
2.1.5 Teva Recent Developments and Future Plans
2.2 Novartis
2.2.1 Novartis Details
2.2.2 Novartis Major Business
2.2.3 Novartis Repurposed Drugs Product and Solutions
2.2.4 Novartis Repurposed Drugs Revenue, Gross Margin and Market Share (2019-2021)
2.2.5 Novartis Recent Developments and Future Plans
2.3 Mylan
2.3.1 Mylan Details
2.3.2 Mylan Major Business
2.3.3 Mylan Repurposed Drugs Product and Solutions
2.3.4 Mylan Repurposed Drugs Revenue, Gross Margin and Market Share (2019-2021)
2.3.5 Mylan Recent Developments and Future Plans
2.4 Johnson & Johnson
2.4.1 Johnson & Johnson Details
2.4.2 Johnson & Johnson Major Business
2.4.3 Johnson & Johnson Repurposed Drugs Product and Solutions
2.4.4 Johnson & Johnson Repurposed Drugs Revenue, Gross Margin and Market Share (2019-2021)
2.4.5 Johnson & Johnson Recent Developments and Future Plans
2.5 Pfizer
2.5.1 Pfizer Details
2.5.2 Pfizer Major Business
2.5.3 Pfizer Repurposed Drugs Product and Solutions
2.5.4 Pfizer Repurposed Drugs Revenue, Gross Margin and Market Share (2019-2021)
2.5.5 Pfizer Recent Developments and Future Plans
2.6 Bausch Health
2.6.1 Bausch Health Details
2.6.2 Bausch Health Major Business
2.6.3 Bausch Health Repurposed Drugs Product and Solutions
2.6.4 Bausch Health Repurposed Drugs Revenue, Gross Margin and Market Share (2019-2021)
2.6.5 Bausch Health Recent Developments and Future Plans
2.7 GSK
2.7.1 GSK Details
2.7.2 GSK Major Business
2.7.3 GSK Repurposed Drugs Product and Solutions
2.7.4 GSK Repurposed Drugs Revenue, Gross Margin and Market Share (2019-2021)
2.7.5 GSK Recent Developments and Future Plans
2.8 ChemRar Group
2.8.1 ChemRar Group Details
2.8.2 ChemRar Group Major Business
2.8.3 ChemRar Group Repurposed Drugs Product and Solutions
2.8.4 ChemRar Group Repurposed Drugs Revenue, Gross Margin and Market Share (2019-2021)
2.8.5 ChemRar Group Recent Developments and Future Plans
2.9 Glenmark
2.9.1 Glenmark Details
2.9.2 Glenmark Major Business
2.9.3 Glenmark Repurposed Drugs Product and Solutions
2.9.4 Glenmark Repurposed Drugs Revenue, Gross Margin and Market Share (2019-2021)
2.9.5 Glenmark Recent Developments and Future Plans
2.10 Fujifilm
2.10.1 Fujifilm Details
2.10.2 Fujifilm Major Business
2.10.3 Fujifilm Repurposed Drugs Product and Solutions
2.10.4 Fujifilm Repurposed Drugs Revenue, Gross Margin and Market Share (2019-2021)
2.10.5 Fujifilm Recent Developments and Future Plans
2.11 Dr. Reddy
2.11.1 Dr. Reddy Details
2.11.2 Dr. Reddy Major Business
2.11.3 Dr. Reddy Repurposed Drugs Product and Solutions
2.11.4 Dr. Reddy Repurposed Drugs Revenue, Gross Margin and Market Share (2019-2021)
2.11.5 Dr. Reddy Recent Developments and Future Plans
2.12 R-Pharma
2.12.1 R-Pharma Details
2.12.2 R-Pharma Major Business
2.12.3 R-Pharma Repurposed Drugs Product and Solutions
2.12.4 R-Pharma Repurposed Drugs Revenue, Gross Margin and Market Share (2019-2021)
2.12.5 R-Pharma Recent Developments and Future Plans
3 Market Competition, by Players
3.1 Global Repurposed Drugs Revenue and Share by Players (2019-2021)
3.2 Market Concentration Rate
3.2.1 Top 3 Repurposed Drugs Players Market Share
3.2.2 Top 10 Repurposed Drugs Players Market Share
3.2.3 Market Competition Trend
3.3 Repurposed Drugs Players Head Office, Products and Services Provided
3.4 Mergers & Acquisitions
3.5 New Entrants and Expansion Plans
4 Market Size Segment by Type
4.1 Global Repurposed Drugs Revenue and Market Share by Type (2016-2021)
4.2 Global Repurposed Drugs Market Forecast by Type (2021-2026)
5 Market Size Segment by Application
5.1 Global Repurposed Drugs Revenue Market Share by Application (2016-2021)
5.2 Repurposed Drugs Market Forecast by Application (2021-2026)
6 North America by Country, by Type, and by Application
6.1 North America Repurposed Drugs Revenue by Type (2016-2026)
6.2 North America Repurposed Drugs Revenue by Application (2016-2026)
6.3 North America Repurposed Drugs Market Size by Country
6.3.1 North America Repurposed Drugs Revenue by Country (2016-2026)
6.3.2 United States Repurposed Drugs Market Size and Forecast (2016-2026)
6.3.3 Canada Repurposed Drugs Market Size and Forecast (2016-2026)
6.3.4 Mexico Repurposed Drugs Market Size and Forecast (2016-2026)
7 Europe by Country, by Type, and by Application
7.1 Europe Repurposed Drugs Revenue by Type (2016-2026)
7.2 Europe Repurposed Drugs Revenue by Application (2016-2026)
7.3 Europe Repurposed Drugs Market Size by Country
7.3.1 Europe Repurposed Drugs Revenue by Country (2016-2026)
7.3.2 Germany Repurposed Drugs Market Size and Forecast (2016-2026)
7.3.3 France Repurposed Drugs Market Size and Forecast (2016-2026)
7.3.4 United Kingdom Repurposed Drugs Market Size and Forecast (2016-2026)
7.3.5 Russia Repurposed Drugs Market Size and Forecast (2016-2026)
7.3.6 Italy Repurposed Drugs Market Size and Forecast (2016-2026)
8 Asia-Pacific by Region, by Type, and by Application
8.1 Asia-Pacific Repurposed Drugs Revenue by Type (2016-2026)
8.2 Asia-Pacific Repurposed Drugs Revenue by Application (2016-2026)
8.3 Asia-Pacific Repurposed Drugs Market Size by Region
8.3.1 Asia-Pacific Repurposed Drugs Revenue by Region (2016-2026)
8.3.2 China Repurposed Drugs Market Size and Forecast (2016-2026)
8.3.3 Japan Repurposed Drugs Market Size and Forecast (2016-2026)
8.3.4 South Korea Repurposed Drugs Market Size and Forecast (2016-2026)
8.3.5 India Repurposed Drugs Market Size and Forecast (2016-2026)
8.3.6 Southeast Asia Repurposed Drugs Market Size and Forecast (2016-2026)
8.3.7 Australia Repurposed Drugs Market Size and Forecast (2016-2026)
9 South America by Country, by Type, and by Application
9.1 South America Repurposed Drugs Revenue by Type (2016-2026)
9.2 South America Repurposed Drugs Revenue by Application (2016-2026)
9.3 South America Repurposed Drugs Market Size by Country
9.3.1 South America Repurposed Drugs Revenue by Country (2016-2026)
9.3.2 Brazil Repurposed Drugs Market Size and Forecast (2016-2026)
9.3.3 Argentina Repurposed Drugs Market Size and Forecast (2016-2026)
10 Middle East & Africa by Country, by Type, and by Application
10.1 Middle East & Africa Repurposed Drugs Revenue by Type (2016-2026)
10.2 Middle East & Africa Repurposed Drugs Revenue by Application (2016-2026)
10.3 Middle East & Africa Repurposed Drugs Market Size by Country
10.3.1 Middle East & Africa Repurposed Drugs Revenue by Country (2016-2026)
10.3.2 Turkey Repurposed Drugs Market Size and Forecast (2016-2026)
10.3.3 Saudi Arabia Repurposed Drugs Market Size and Forecast (2016-2026)
10.3.4 UAE Repurposed Drugs Market Size and Forecast (2016-2026)
11 Research Findings and Conclusion
12 Appendix
12.1 Methodology
12.2 Research Process and Data Source
12.3 Disclaimer
Table 1. Global Repurposed Drugs Revenue by Type, (USD Million), 2020 VS 2021 VS 2026
Table 2. Global Repurposed Drugs Revenue by Application, (USD Million), 2020 VS 2021 VS 2026
Table 3. Global Market Repurposed Drugs Revenue (Million USD) Comparison by Region (2016 VS 2021 VS 2026)
Table 4. Global Repurposed Drugs Revenue (USD Million) by Region (2016-2021)
Table 5. Global Repurposed Drugs Revenue Market Share by Region (2021-2026)
Table 6. Teva Corporate Information, Head Office, and Major Competitors
Table 7. Teva Major Business
Table 8. Teva Repurposed Drugs Product and Solutions
Table 9. Teva Repurposed Drugs Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 10. Novartis Corporate Information, Head Office, and Major Competitors
Table 11. Novartis Major Business
Table 12. Novartis Repurposed Drugs Product and Solutions
Table 13. Novartis Repurposed Drugs Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 14. Mylan Corporate Information, Head Office, and Major Competitors
Table 15. Mylan Major Business
Table 16. Mylan Repurposed Drugs Product and Solutions
Table 17. Mylan Repurposed Drugs Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 18. Johnson & Johnson Corporate Information, Head Office, and Major Competitors
Table 19. Johnson & Johnson Major Business
Table 20. Johnson & Johnson Repurposed Drugs Product and Solutions
Table 21. Johnson & Johnson Repurposed Drugs Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 22. Pfizer Corporate Information, Head Office, and Major Competitors
Table 23. Pfizer Major Business
Table 24. Pfizer Repurposed Drugs Product and Solutions
Table 25. Pfizer Repurposed Drugs Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 26. Bausch Health Corporate Information, Head Office, and Major Competitors
Table 27. Bausch Health Major Business
Table 28. Bausch Health Repurposed Drugs Product and Solutions
Table 29. Bausch Health Repurposed Drugs Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 30. GSK Corporate Information, Head Office, and Major Competitors
Table 31. GSK Major Business
Table 32. GSK Repurposed Drugs Product and Solutions
Table 33. GSK Repurposed Drugs Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 34. ChemRar Group Corporate Information, Head Office, and Major Competitors
Table 35. ChemRar Group Major Business
Table 36. ChemRar Group Repurposed Drugs Product and Solutions
Table 37. ChemRar Group Repurposed Drugs Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 38. Glenmark Corporate Information, Head Office, and Major Competitors
Table 39. Glenmark Major Business
Table 40. Glenmark Repurposed Drugs Product and Solutions
Table 41. Glenmark Repurposed Drugs Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 42. Fujifilm Corporate Information, Head Office, and Major Competitors
Table 43. Fujifilm Major Business
Table 44. Fujifilm Repurposed Drugs Product and Solutions
Table 45. Fujifilm Repurposed Drugs Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 46. Dr. Reddy Corporate Information, Head Office, and Major Competitors
Table 47. Dr. Reddy Major Business
Table 48. Dr. Reddy Repurposed Drugs Product and Solutions
Table 49. Dr. Reddy Repurposed Drugs Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 50. R-Pharma Corporate Information, Head Office, and Major Competitors
Table 51. R-Pharma Major Business
Table 52. R-Pharma Repurposed Drugs Product and Solutions
Table 53. R-Pharma Repurposed Drugs Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 54. Global Repurposed Drugs Revenue (USD Million) by Players (2019-2021)
Table 55. Global Repurposed Drugs Revenue Share by Players (2019-2021)
Table 56. Breakdown of Repurposed Drugs by Company Type (Tier 1, Tier 2 and Tier 3)
Table 57. Repurposed Drugs Players Head Office, Products and Services Provided
Table 58. Repurposed Drugs Mergers & Acquisitions in the Past Five Years
Table 59. Repurposed Drugs New Entrants and Expansion Plans
Table 60. Global Repurposed Drugs Revenue (USD Million) by Type (2016-2021)
Table 61. Global Repurposed Drugs Revenue Share by Type (2016-2021)
Table 62. Global Repurposed Drugs Revenue Forecast by Type (2021-2026)
Table 63. Global Repurposed Drugs Revenue by Application (2016-2021)
Table 64. Global Repurposed Drugs Revenue Forecast by Application (2021-2026)
Table 65. North America Repurposed Drugs Revenue by Type (2016-2021) & (USD Million)
Table 66. North America Repurposed Drugs Revenue by Type (2021-2026) & (USD Million)
Table 67. North America Repurposed Drugs Revenue by Application (2016-2021) & (USD Million)
Table 68. North America Repurposed Drugs Revenue by Application (2021-2026) & (USD Million)
Table 69. North America Repurposed Drugs Revenue by Country (2016-2021) & (USD Million)
Table 70. North America Repurposed Drugs Revenue by Country (2021-2026) & (USD Million)
Table 71. Europe Repurposed Drugs Revenue by Type (2016-2021) & (USD Million)
Table 72. Europe Repurposed Drugs Revenue by Type (2021-2026) & (USD Million)
Table 73. Europe Repurposed Drugs Revenue by Application (2016-2021) & (USD Million)
Table 74. Europe Repurposed Drugs Revenue by Application (2021-2026) & (USD Million)
Table 75. Europe Repurposed Drugs Revenue by Country (2016-2021) & (USD Million)
Table 76. Europe Repurposed Drugs Revenue by Country (2021-2026) & (USD Million)
Table 77. Asia-Pacific Repurposed Drugs Revenue by Type (2016-2021) & (USD Million)
Table 78. Asia-Pacific Repurposed Drugs Revenue by Type (2021-2026) & (USD Million)
Table 79. Asia-Pacific Repurposed Drugs Revenue by Application (2016-2021) & (USD Million)
Table 80. Asia-Pacific Repurposed Drugs Revenue by Application (2021-2026) & (USD Million)
Table 81. Asia-Pacific Repurposed Drugs Revenue by Region (2016-2021) & (USD Million)
Table 82. Asia-Pacific Repurposed Drugs Revenue by Region (2021-2026) & (USD Million)
Table 83. South America Repurposed Drugs Revenue by Type (2016-2021) & (USD Million)
Table 84. South America Repurposed Drugs Revenue by Type (2021-2026) & (USD Million)
Table 85. South America Repurposed Drugs Revenue by Application (2016-2021) & (USD Million)
Table 86. South America Repurposed Drugs Revenue by Application (2021-2026) & (USD Million)
Table 87. South America Repurposed Drugs Revenue by Country (2016-2021) & (USD Million)
Table 88. South America Repurposed Drugs Revenue by Country (2021-2026) & (USD Million)
Table 89. Middle East & Africa Repurposed Drugs Revenue by Type (2016-2021) & (USD Million)
Table 90. Middle East & Africa Repurposed Drugs Revenue by Type (2021-2026) & (USD Million)
Table 91. Middle East & Africa Repurposed Drugs Revenue by Application (2016-2021) & (USD Million)
Table 92. Middle East & Africa Repurposed Drugs Revenue by Application (2021-2026) & (USD Million)
Table 93. Middle East & Africa Repurposed Drugs Revenue by Country (2016-2021) & (USD Million)
Table 94. Middle East & Africa Repurposed Drugs Revenue by Country (2021-2026) & (USD Million)
List of Figures
Figure 1. Repurposed Drugs Picture
Figure 2. Global Repurposed Drugs Revenue Market Share by Type in 2020
Figure 3. Generic Drugs
Figure 4. Clinical Trial Failed Drugs
Figure 5. Repurposed Drugs Revenue Market Share by Application in 2020
Figure 6. Cardiovascular Diseases Picture
Figure 7. Mental Illness Picture
Figure 8. Cancer Picture
Figure 9. Other Picture
Figure 10. Global Repurposed Drugs Revenue, (USD Million): 2020 VS 2021 VS 2026
Figure 11. Global Repurposed Drugs Revenue and Forecast (2016-2026) & (USD Million)
Figure 12. Global Repurposed Drugs Revenue Market Share by Region (2016-2026)
Figure 13. Global Repurposed Drugs Revenue Market Share by Region in 2020
Figure 14. North America Repurposed Drugs Revenue (USD Million) and Growth Rate (2016-2026)
Figure 15. Europe Repurposed Drugs Revenue (USD Million) and Growth Rate (2016-2026)
Figure 16. Asia-Pacific Repurposed Drugs Revenue (USD Million) and Growth Rate (2016-2026)
Figure 17. South America Repurposed Drugs Revenue (USD Million) and Growth Rate (2016-2026)
Figure 18. Middle East and Africa Repurposed Drugs Revenue (USD Million) and Growth Rate (2016-2026)
Figure 19. Repurposed Drugs Market Drivers
Figure 20. Repurposed Drugs Market Restraints
Figure 21. Repurposed Drugs Market Trends
Figure 22. Teva Recent Developments and Future Plans
Figure 23. Novartis Recent Developments and Future Plans
Figure 24. Mylan Recent Developments and Future Plans
Figure 25. Johnson & Johnson Recent Developments and Future Plans
Figure 26. Pfizer Recent Developments and Future Plans
Figure 27. Bausch Health Recent Developments and Future Plans
Figure 28. GSK Recent Developments and Future Plans
Figure 29. ChemRar Group Recent Developments and Future Plans
Figure 30. Glenmark Recent Developments and Future Plans
Figure 31. Fujifilm Recent Developments and Future Plans
Figure 32. Dr. Reddy Recent Developments and Future Plans
Figure 33. R-Pharma Recent Developments and Future Plans
Figure 34. Global Repurposed Drugs Revenue Share by Players in 2020
Figure 35. Repurposed Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
Figure 36. Global Top 3 Players Repurposed Drugs Revenue Market Share in 2020
Figure 37. Global Top 10 Players Repurposed Drugs Revenue Market Share in 2020
Figure 38. Key Players Market Share Trend (Top 3 Market Share: 2019 VS 2020 VS 2021)
Figure 39. Global Repurposed Drugs Revenue Share by Type in 2020
Figure 40. Global Repurposed Drugs Market Share Forecast by Type (2021-2026)
Figure 41. Global Repurposed Drugs Revenue Share by Application in 2020
Figure 42. Global Repurposed Drugs Market Share Forecast by Application (2021-2026)
Figure 43. North America Repurposed Drugs Sales Market Share by Type (2016-2026)
Figure 44. North America Repurposed Drugs Sales Market Share by Application (2016-2026)
Figure 45. North America Repurposed Drugs Revenue Market Share by Country (2016-2026)
Figure 46. United States Repurposed Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 47. Canada Repurposed Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 48. Mexico Repurposed Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 49. Europe Repurposed Drugs Sales Market Share by Type (2016-2026)
Figure 50. Europe Repurposed Drugs Sales Market Share by Application (2016-2026)
Figure 51. Europe Repurposed Drugs Revenue Market Share by Country (2016-2026)
Figure 52. Germany Repurposed Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 53. France Repurposed Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 54. United Kingdom Repurposed Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 55. Russia Repurposed Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 56. Italy Repurposed Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 57. Asia-Pacific Repurposed Drugs Sales Market Share by Type (2016-2026)
Figure 58. Asia-Pacific Repurposed Drugs Sales Market Share by Application (2016-2026)
Figure 59. Asia-Pacific Repurposed Drugs Revenue Market Share by Region (2016-2026)
Figure 60. China Repurposed Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 61. Japan Repurposed Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 62. South Korea Repurposed Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 63. India Repurposed Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 64. Southeast Asia Repurposed Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 65. Australia Repurposed Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 66. South America Repurposed Drugs Sales Market Share by Type (2016-2026)
Figure 67. South America Repurposed Drugs Sales Market Share by Application (2016-2026)
Figure 68. South America Repurposed Drugs Revenue Market Share by Country (2016-2026)
Figure 69. Brazil Repurposed Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 70. Argentina Repurposed Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 71. Middle East and Africa Repurposed Drugs Sales Market Share by Type (2016-2026)
Figure 72. Middle East and Africa Repurposed Drugs Sales Market Share by Application (2016-2026)
Figure 73. Middle East and Africa Repurposed Drugs Revenue Market Share by Country (2016-2026)
Figure 74. Turkey Repurposed Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 75. Saudi Arabia Repurposed Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 76. UAE Repurposed Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 77. Methodology
Figure 78. Research Process and Data Source
世界のボツリヌス中毒症治療薬市場 2021：企業別、地域別、種類・用途別 The Botulism Illness Drugs market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulati…- 世界の脊髄性筋萎縮症（SMA）治療薬市場 2021：企業別、地域別、種類・用途別 The Spinal Muscular Atrophy (SMA) Drugs market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, t…
- 世界の凍結乾燥注射剤市場 2021：企業別、地域別、種類・用途別 The Lyophilized Injectable Drugs market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade re…
- 世界のクリプトコッカス症治療薬市場 2021：企業別、地域別、種類・用途別 The Cryptococcosis Drugs market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulation…
- 世界の心理療法薬市場 2021：企業別、地域別、種類・用途別 The Psychotherapeutic Drugs market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulat…